Evidence map›Paper›PMID 21569346›Full record

ArticleBMC medical research methodology2011

Adjusting a cancer mortality-prediction model for disease status-related eligibility criteria.

Millennia Foy, Xing Chen, Marek Kimmel, Olga Y Gorlova

Open access · goldAbstract read
In one paragraph

Article in BMC medical research methodology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Millennia FoyBrown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, 1825 Pressler St, Houston, TX 77030, USA. millennia.foy@uth.tmc.edu
Xing Chen
Marek Kimmel
Olga Y Gorlova
The University of Texas MD Anderson Cancer Center · USBrown Foundation · USRice University · US

Funding

A genomewide study of lung cancer in never smokersR01CA149462 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GORLOVA, OLGA · 2010 to 2014
$4.4M
Modeling Lung Cancer: Risks, Progression, and ScreeningU01CA097431 · NCI · RICE UNIVERSITY · PI KIMMEL, MAREK · 2002 to 2009
$1.8M
NCI NIH HHS 5U01CA097431 CISNETNCI NIH HHS R01 CA149462NCI NIH HHS R25 CA57780
6 · The paper itself

Abstract

backgroundVolunteering participants in disease studies tend to be healthier than the general population partially due to specific enrollment criteria. Using modeling to accurately predict outcomes of cohort studies enrolling volunteers requires adjusting for the bias introduced in this way. Here we propose a new method to account for the effect of a specific form of healthy volunteer bias resulting from imposing disease status-related eligibility criteria, on disease-specific mortality, by explicitly modeling the length of the time interval between the moment when the subject becomes ineligible for the study, and the outcome.

methodsUsing survival time data from 1190 newly diagnosed lung cancer patients at MD Anderson Cancer Center, we model the time from clinical lung cancer diagnosis to death using an exponential distribution to approximate the length of this interval for a study where lung cancer death serves as the outcome. Incorporating this interval into our previously developed lung cancer risk model, we adjust for the effect of disease status-related eligibility criteria in predicting the number of lung cancer deaths in the control arm of CARET. The effect of the adjustment using the MD Anderson-derived approximation is compared to that based on SEER data.

resultsUsing the adjustment developed in conjunction with our existing lung cancer model, we are able to accurately predict the number of lung cancer deaths observed in the control arm of CARET.

conclusionsThe resulting adjustment was accurate in predicting the lower rates of disease observed in the early years while still maintaining reasonable prediction ability in the later years of the trial. This method could be used to adjust for, or predict the duration and relative effect of any possible biases related to disease-specific eligibility criteria in modeling studies of volunteer-based cohorts.

Indexed as

Research DesignAdultAgedCarotenoidsCohort StudiesEligibility DeterminationForecastingHumansKaplan-Meier EstimateLung NeoplasmsMiddle AgedPrognosisSelection BiasSmokingTreatment OutcomeVitamin ACarotenoidsVitamin A

Identifiers

PMID21569346
PMCPMC3112196
OpenAlexW2159589545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.